Purdue Pharma’s bankruptcy case was heard before the Supreme Court of the United States in December 2023. In June 2024, the Court voted 5-4 against third-party releases contained in the Plan of Reorganization. The decision does nothing to deter us from the twin goals of using settlement dol...
A narrowly divided Supreme Court in a 5-4decisionstruck down a hard-fought bankruptcy plan for OxyContin manufacturer Purdue Pharma that would have awarded $6 billion to state and local governments to fight opioid addiction and payouts to more than 100,000 ...
November 1, 2024 Purdue Pharma is close to a new bankruptcy settlement with its owners, members of the wealthy Sackler family, and state and local governments that have filed lawsuits alleging that its painkiller OxyContin spurred a deadly opioid-addiction crisis in the U.S., … ...
The Supreme Court on Thursday derailed a multi-billion-dollar bankruptcy plan for Purdue Pharma, the maker of OxyContin, siding with the Biden administration.
Purdue Pharma has agreed to pay over $4.5bn to resolve a multi-state lawsuit for its alleged role in driving the opioid crisis in the US.
The ruling means that settlement talks must be reset, which ultimately means more time. Purdue Pharma and the billionaire Sacklers have long been viewed as the source of America’s opioid crisis, starting in the 1990s with the debut of prescription painkiller OxyContin. The crisis has since mor...
New York Attorney General Letitia James, like several others, sued Sackler family members and opposed the settlement before eventually agreeing to it this year. She said in a statement that if the deal doesn't hold up, she's ready to resume the civil lawsuit: "Purdue Pharma and the Sackler...
Proposed settlements between the federal government and OxyContin maker Purdue Pharma and its owners cleared a major legal hurdle Tuesday when a bankruptcy judge said they could move ahead.
The US Justice Department has challenged a plan that would dissolve Purdue Pharma, manufacturer of the OxyContin drug that has been blamed for the country's opioid crisis, while shielding its founders from lawsuits.
Stay up-to-date with breaking news and top stories on Purdue Pharma LP. In-depth analysis, industry insights and expert opinion